Showing results (701-710 of 16,804) with videos related to

Sort By:
Pageof 1,681
British Journal of Haematology|October 9, 2003
Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)Xiuqing Ru, Howard A Liebman
British Journal of Haematology|October 9, 2003
DNA microarray analysis of stage progression mechanism in myelodysplastic syndromeMasuzu Ueda, Jun Ota, Yoshihiro Yamashita, et al.
British Journal of Haematology|October 9, 2003
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myelomaMichael A Thompson, Thomas E Witzig, Shaji Kumar, et al.
British Journal of Haematology|October 9, 2003
A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic techniqueAnorew S Lawrie, Elaine Gray, Dave Leeming, et al.
British Journal of Haematology|October 9, 2003
Causes of death in sickle cell disease: an autopsy studyElizabeth A Manci, Donald E Culberson, Yih-Ming Yang, et al.
British Journal of Haematology|September 27, 2003
Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survivalTsuyoshi Nakamaki, Yasuharu Hamano, Jun-Ichi Hisatake, et al.
British Journal of Haematology|September 27, 2003
Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphomaStephanie Guyomard, Gilles Salles, Marie Coudurier, et al.
British Journal of Haematology|September 27, 2003
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusionFrédéric Baron, Pascale Frère, Georges Fillet, et al.
British Journal of Haematology|September 27, 2003
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicityRizwana Chohan, Ravi Vij, Douglas Adkins, et al.
British Journal of Haematology|September 27, 2003
Quiescent CD34+ early erythroid progenitors are resistant to several erythropoietic 'inhibitory' cytokines; role of FLIPJanina Ratajczak, Magdalena Kucia, Ryan Reca, et al.
Pageof 1,681